Ovid Therapeutics

OVID • NASDAQ • Stock Fundamentals

Ovid Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Margaret Alexander, with a market cap of $461.0M.

Market Cap$461.0M

Employees40.0

CEOMargaret Alexander

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 12, 2026 · 16 days agoQ1 2026

Next EarningsAug 12, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Ovid Therapeutics

Ovid Therapeutics (OVID) has a market capitalization of $461.0M and trades on NASDAQ.

Ovid Therapeutics has approximately 40 employees.